sacituzumab
gilead
['sacituzumab', 'breast', 'tropics-02', 'sacitu, govi']
the spoke with live at asco 2023 about the tropics-02 studies assessing sacituzumab govitecan for hr+/her2 metastatic breast cancer. keep an eye out for the video on docwire news, coming soon! #asco2023 
DocWire News delivers the most relevant medical news to over 1M HCPs daily.